Ketogenic diets are shown to influence the microbiome, leading to the production of metabolites like indolactate, which can reduce inflammation throughout the body, including the brain. Various mechanisms, such as changes in neurotransmitter balance and gene expression, highlight the complexity of how these diets impact neurological and autoimmune conditions. Despite the promising results from clinical trials, funding challenges remain a significant barrier to further research in this area.
